Immunization of ovarian cancer patients with a synthetic Lewis(y)- protein conjugate vaccine: A phase 1 trial

International Journal of Cancer

Volumn 87, Issue 1, 2000, Pages 79-85

  Sabbatini, Paul J ^a,b   Kudryashov, Valery ^b   Ragupathi, Govindaswami ^a   Danishefsky, Samuel J ^b   Livingston, Philip O ^a   Bornmann, William ^b   Spassova, Maria ^b   Zatorski, Andrzej ^b   Spriggs, David ^a   Aghajanian, Carol ^a   Soignet, Steven ^a   Peyton, Madeline ^a   O'Flaherty, Catherine ^a   Curtin, John ^a   Lloyd, Kenneth O ^b  

^a Memorial Hospital   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GLYCOPROTEIN; KEYHOLE LIMPET HEMOCYANIN;

ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT DEPENDENT CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TARGET CELL;

EID: 0004825568     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000701)87:1<79::AID-IJC12>3.0.CO;2-L     Document Type: Article

References (22)

1. BRADFORD, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
2. b blood group determinants and of H-type I and H-type II oligosaccharides. J. Amer. chem. Soc., 117, 5701-5711 (1995).
3. DANISHEFSKY, S.J. and BILODEAU, M.T., Glycals in organic synthesis: the evolution of comprehensive strategies for the assembly of oligosaccharides and glycoconjugates of biological consequence. Angew. Chem. Int. (ed. Engl.), 35, 1380-1419 (1996).
4. FEDERICI, M.G., KUDRYASHOV, V., SAIGO, P.E., FINSTAD, C.L., and LLOYD, K.O., Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immuno-therapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int. J. Cancer, 81, 193-198 (1999).
5. FURUKAWA, K., CLAUSEN, H., HAKOMORI, S., SAKAMOTO, J., LOOK, K., LUNDBLAD, A., MATTES, M.J., and LLOYD, K.O., Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry, 24, 7820-7826 (1985).
6. HELLSTRÖM, I., GARRIGUES, H.J., GARRIGUES, U., and HELLSTRÖM, K.E., Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Lewis y-related cell surface antigens. Cancer Res., 50, 2183-2190 (1990).
7. KITAMURA, K., STOCKERT, E., GARIN-CHESA, P., WELT, S., LLOYD, K.O., AMOUR, K.L., WALLACE, T.P., HARRIS, W.J., CARR, F.J., and OLD, L.J., Specificity analysis of Le y antibodies generated against synthetic and natural Le y determinants. Proc. not. Acad. Sci. (Wash.), 91, 12957-12961 (1994).
8. KUDRYASHOV, V., KIM, H.M., RAGUPATHI, G., DANISHEFSKY, S.J., LIVINGSTON, P.O., and LLOYD, K.O., Immunogenicity of synthetic Lewis Y oligosaccharide-protein conjugates in mice: towards the design of anticancer vaccines. Cancer Immunol. Immunother., 45, 281-286 (1997).
9. LIVINGSTON, P.O., ADLURI, S., HELLING, F., YAO, T.-J., KENSIL, C.R., NEWMAN, M.J., and MARCIANI, D., Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine, 12, 1275-1280 (1994).
10. LIVINGSTON, P.O., ZHANG, S., and LLOYD, K.O., Carbohydrate vaccines that induce antibodies against cancer 1. Rationale. Cancer Immunol. Immunother., 45, 1-9 (1997).
11. LLOYD, K.O., KABAT, E.A., LAYUG, E.J., and GRUEZO, P., Immunochemical studies on blood groups. XXXIV. Structures of some oligosaccharides produced by alkaline degradation of blood group A, B, and H substances. Biochemistry, 5, 1489-1501 (1966).
12. LLOYD, K.O. and SAVAGE, A., High-performance anion exchange (HPAE) chromatography of reduced oligosaccharides from sialomucins. Glycoconjugate J., 8, 493-498 (1991).
13. MARKMAN, M., KENNEDY, A., WEBSTER, K., KULP, B., PETERSON, G., and BELINSON, J., Continued chemosensitivity to cisplatin/carboplatin in ovarian cancer despite treatment with multiple prior platinum containing regimens. Gyn. Oncol., 65, 434-436 (1997).
14. MCGUIRE, W.P., HOSKINS, W.J., BRADY, M.F., KUCERA, P.R., PARTRIDGE, E.E., LOOK, K.Y., CLARKE-PEARSON, D.L., and DAVIDSON, M., Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N. Engl. J. Med., 334, 1-6 (1996).
15. MILES, D.W., TOWLSON, K.E., GRAHAM, R., REDDISH, M., LONGENECKER. B.M., TAYLOR-PAPADIMITRIUU, J., and RUBENS, R.D., A randomised phase II study of sialyl-Tn and detox-B adjuvant with or without cyclophospha-mide pretreatment for the active specific immunotherapy of breast cancer. Brit. J. Cancer. 74, 1292-1296 (1996).
16. SLOVIN, S.F. and 14 OTHERS, Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc. nal. Acatl. Sci. (Wash.) 96, 5710-5715 (1999).
17. SPEISER, D.E., MIRANDA, R., ZAKARIAN, A., BACHMAN, M.F., MCKALLFAIENZA, K., ODERMATT, B., HANAHAN, D., ZINKERNAGEL., R.M., and OHASHI, P. S., Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. exp. Med., 186;645-653 (1997).
18. TEMPERO, R.M., ROWSE, G.J., GENDLER, S.J., and HOLLINGSWORTH, M.A., Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenie mice. Int. J. Cancer. 80, 595-599 (1999).
19. TOOLCHER, A.W., SUGARMAN, S., GELMON, K.A., COHEN, R., SALEH, M., ISAACS, C., YOUNG, L., HEALEY, D., ONETTO, N., and SLICHENMYER, W., Randomized phase II study of BR96-doxurubicin conjugate in patients with metastatic breast center. J. clin. Oncol., 17, 478-484 (1999).
20. WEBER, L.W., BOWNE, W.B., WOKCHOK, J.D., SRINIVASAN, R., QIN, J., MOROK, Y., CLYNES, R., SONG, P., LEWIS, J.J., and HOUGHTON, A.N., Tumor immunity and autoimmunity induced by immunization with homologous DNA. J. clin. Invest., 102, 1258-1264 (1998).
21. y) blood group antigen expression in epithelial ovarian cancer. Int. J. Cancer, 65, 406-412 (1996).
22. ZHANG, S., ZHANG, H.S., CORDON-CARDO, C., REUTER, V.E., SINGHAL, A.K., LLOYD, K.O., and LIVINGSTON, P.O., Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int. J Cancer. 73, 50-56 (1997).